BIOCOM AG's articles

  1. Biotechnology
In the largest expansion in the company’s 150-year history, the Laupheim-headquartered CDMO Rentschler Biopharma SE has launched a new production line at its site in Milford, USA. According to a company spokesperson, the expansion in the main market for biopharmaceuticals doubles Rentschler’s cGMP-compliant production capacity in one fell swoop. Production for a long-standing client at […]
  1. Biotechnology
NLC Health Ventures (Amsterdam, The Netherlands), in partnership with Verily, the precision health technology daughter company of Alphabet/Google, will launch Exolvo Biosciences, a pioneering biotech company providing the next-generation solution for biologic drug delivery as oral administration. NLC Health Ventures launches a new early-stage drug delivery company. The venture builder from The Netherlands partners with […]
  1. Biotechnology
ITM Isotope Technologies Munich SE has raised €188m ito boost radiopharma pipeline, contract manufacturing cpacity, and launch ITM-11. Radiopharma conjugate specialist Isotope Technologies Munich SE has raised €188m in an equity financing led by globally active investor Temasek. BlackRock, Qatar Investment Authority (QIA), ATHOS and Carbyne participated in the financing that will be used to […]
  1. Biotechnology
Waste primarily based biosurfactants producer Amphistar BV has closed a €6m funding spherical led by the  European Round Bioeconomy Fund (ECBF), Qbic III and Flanders Future Tech Fund (FFTF). The infusion of €6m in new capital from ECBF, Qbic III and FFTF will empower AmphiStar to kickstart industrial biosurfactant manufacturing in collaboration with exterior companions. […]
  1. Biotechnology
With a brand new legislation, the German authorities desires to extend the variety of medical trials carried out in Germany and make the nation primary in Europe once more. The draft Medical Analysis Act (Medizinforschungsgesetz) introduced by Well being Minister Karl Lauterbach in Berlin earlier than Easter is the centrepiece of Germany’s pharmaceutical technique. With […]
  1. Biotechnology
The Innovative Medicine Initiative 2 JU-funded €25m project COMBINE is joining forces with  CARB-X & CAIRD, iiCON and Pharmacology Discovery Services to improve in vivo antibiotics testing. The development of novel antibiotics is crucial in the fight against antimicrobial resistance (AMR) but has been neglected for decades due to a lack of development incentives. Another […]
  1. Biotechnology
The 29th BIO-Europe in Munich was able to boast record figures: around 6,000 participants for the first time, over 30,000 partnering meetings for the first time at what was already the largest European partnering event for biotech and pharma. However, many other figures are currently pointing back to 2019. Record figures and a much better […]
  1. Biotechnology
Pierre Fabre Laboratories SA has extended its global partnership with Atara Biotherapeutics, licencing tabelecleucel commercialisation rights for Northern America and beyond. Paris-based Pierre Fabre Laboratories SA already held a licence for the EU-approved tabelecleucel, an allogeneic T cell based second-line treatment of adult and pediatric patients two years of age and older with relapsed or […]
  1. Biotechnology
AstraZeneca plc has paid French cancer cell therapy developer Cellectis SA US$25m upfront and US$220m in equity in an US$2.2bn R&D deal for up to ten cell and gene therapies. Under the co-development agreement, that includes a US$80m equity investment and an option for a further equity investment of US$140m by AstraZeneca plc into Cellectis […]
  1. Biotechnology
BioNtech SE has reported preliminary Phase I/II results with BNT211-01 (NEO-PTC-01) and CarVAC at ESMO conference in Madrid Testing different dose levels of its adoptive cell therapy BNT.221-01, a combination of Claudin 6 (CLDN6)-targeted Car-T cells (derived from NEO-PTC-01, initially developed by tody’s BioNTech subsidiary Neon Therapeutics) and the mRNA-based Car-T  booster CarVac (CAR-T cell […]
  1. Biotechnology
Antiverse Ltd and GlobalBio Inc. have extend their cancer antibody partnership to progress two PD-1 modulators to preclinial development AI specialist Antiverse Ltd (Cardiff, UK) and antobody engeeniering expert GlobalBio, Inc. (New York, USA) will be extending their collaboration to advance immune checkpoint inhibitors in cancer therapy. The initial collaboration successfully resulted in the generation […]

Login

Welcome to Life Science News!

"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.